1
|
Garcia-Vilanova A, Olmo-Fontánez AM, Moliva JI, Allué-Guardia A, Singh H, Merritt RE, Maselli DJ, Peters JI, Restrepo BI, Wang Y, Schlesinger LS, Turner J, Weintraub ST, Torrelles JB. The aging human lung mucosa: A proteomics study. J Gerontol A Biol Sci Med Sci 2022; 77:1969-1974. [PMID: 35460553 PMCID: PMC9536443 DOI: 10.1093/gerona/glac091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Indexed: 11/13/2022] Open
Abstract
The older adult population, estimated to double by 2050, is at increased risk of respiratory infections and other pulmonary diseases. Biochemical changes in the lung alveolar lining fluid (ALF) and in alveolar compartment cells can alter local immune responses as we age, generating opportunities for invading pathogens to establish successful infections. Indeed, the lung alveolar space of older adults is a pro-inflammatory, pro-oxidative, dysregulated environment that remains understudied. We performed an exploratory, quantitative proteomic profiling of the soluble proteins present in ALF, developing insight into molecular fingerprints, pathways, and regulatory networks that characterize the alveolar space in old age, comparing it to that of younger individuals. We identified 457 proteins that were significantly differentially expressed in older adult ALF, including increased production of matrix metalloproteinases, markers of cellular senescence, antimicrobials, and proteins of neutrophilic granule origin, among others, suggesting that neutrophils in the lungs of older adults could be potential contributors to the dysregulated alveolar environment with increasing age. Finally, we describe a hypothetical regulatory network mediated by the Serum Response Factor that could explain the neutrophilic profile observed in the older adult population.
Collapse
Affiliation(s)
- Andreu Garcia-Vilanova
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX
| | - Angélica M Olmo-Fontánez
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX.,Integrated Biomedical Sciences Program, The University of Texas Health Science Center at San Antonio, TX
| | - Juan I Moliva
- Vaccine Research Center; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
| | - Anna Allué-Guardia
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX
| | - Harjinder Singh
- Division of Pulmonary and Critical Care Medicine, School of Medicine, UT-Health SA, San Antonio, TX
| | - Robert E Merritt
- Department of Surgery, College of Medicine, The Ohio State University, Columbus OH
| | - Diego J Maselli
- Division of Pulmonary and Critical Care Medicine, School of Medicine, UT-Health SA, San Antonio, TX
| | - Jay I Peters
- Division of Pulmonary and Critical Care Medicine, School of Medicine, UT-Health SA, San Antonio, TX
| | | | - Yufeng Wang
- Department of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, UTSA, San Antonio, TX
| | - Larry S Schlesinger
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX
| | - Joanne Turner
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX
| | - Susan T Weintraub
- Department of Biochemistry and Structural Biology, UT-Health SA, San Antonio, TX
| | - Jordi B Torrelles
- Population Health and Host Pathogen Interactions Programs, Texas Biomedical Research Institute, San Antonio, TX
| |
Collapse
|